Download this White Paper to Learn More
Specialty medicines are on track to represent over half of total drug spend in leading developed markets by 2028. To capitalize on this opportunity and cut through payer, pricing and regulatory headwinds requires sound commercial and distribution strategies.
Why? Because you only have one chance to launch a new product. And when you do, it’s important that patients can access that product when and where they need it.
This whitepaper walks you through what it takes to develop an optimal distribution strategy for commercial success.
In it, you’ll discover:
- The five-year market outlook for specialty medicines
- Growth opportunities and challenges for the specialty market and distribution
- Solutions to help companies evaluate and optimize their channel strategy
Offered Free by: Cencora
See All Resources from: Cencora
